Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nifedipine Plus Magnesium Sulfate for Tocolysis in Threatened Preterm Labor
NCT05345132Recruiting
- Sponsor
- Assiut University
- Start
- Apr 2022
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of nifedipine GITS in Preterm labor (PTL) (2 arms), sponsored by Assiut University. Primary endpoint: Number of women not delivered within 48 hours of starting tocolytic therapy. Started Apr 2022; status: recruiting.
02
Drugs
nifedipine GITS
03
Conditions
Preterm labor (PTL)
Beyond the preview
Go deeper on NCT05345132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05345132.